INVEGA HAFYERA®
(paliperidone palmitate 6-month)
INVEGA HAFYERA® (paliperidone palmitate 6-month)
Clinical Trial Publications
- Najarian D, Sanga P, Wang S, et al. A randomized, double-blind, multicenter, noninferiority study comparing paliperidone palmitate 6-month versus the 3-month long-acting injectable in patients with schizophrenia [published online ahead of print, 2021 Nov 13]. Int J Neuropsychopharmacol. 2021. doi: 10.1093/ijnp/pyab071.